These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33025409)

  • 1. Chlorhexidine-impregnated sponge dressing for prevention of catheter exit-site infection in peritoneal dialysis patients: a pilot study.
    Htay H; Choo JCJ; Johnson DW; Pascoe EM; Jayaballa M; Oei EL; Ng LC; Wu SY; Foo MWY
    Int Urol Nephrol; 2021 Apr; 53(4):803-812. PubMed ID: 33025409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
    Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
    Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
    Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
    Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
    Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
    Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between types of dressing following catheter insertion and early exit-site infection in peritoneal dialysis.
    Figueiredo AE; de Mattos C; Saraiva C; Olandoski M; Barretti P; Pecoits Filho R; de Moraes TP;
    J Clin Nurs; 2017 Nov; 26(21-22):3658-3663. PubMed ID: 28122398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fungal peritoneal dialysis catheter-related exit-site infection combined with tunnel infection: A case report].
    Qiao J; Lu LX; He YT; Men CC; Chu XX; Wu B; Zhao HP; Wang M
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):748-754. PubMed ID: 37534662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients.
    Johnson DW; Clark C; Isbel NM; Hawley CM; Beller E; Cass A; de Zoysa J; McTaggart S; Playford G; Rosser B; Thompson C; Snelling P;
    Perit Dial Int; 2009; 29(3):303-9. PubMed ID: 19458303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
    Chen SS; Sheth H; Piraino B; Bender F
    Perit Dial Int; 2016; 36(4):387-9. PubMed ID: 26634567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between keeping home records of catheter exit-site and incidence of peritoneal dialysis-related infections.
    Iida H; Kurita N; Fujimoto S; Kamijo Y; Ishibashi Y; Fukuma S; Fukuhara S
    Int Urol Nephrol; 2018 Apr; 50(4):763-769. PubMed ID: 29349637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients.
    Htay H; Johnson DW; Craig JC; Schena FP; Strippoli GF; Tong A; Cho Y
    Cochrane Database Syst Rev; 2019 May; 5(5):CD004680. PubMed ID: 31149735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis.
    Rodríguez-Carmona A; Pérez-Fontán M; López-Muñiz A; Ferreiro-Hermida T; García-Falcón T
    Perit Dial Int; 2014; 34(6):618-26. PubMed ID: 23818005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorhexidine-impregnated sponge versus chlorhexidine gel dressing for short-term intravascular catheters: which one is better?
    Buetti N; Ruckly S; Schwebel C; Mimoz O; Souweine B; Lucet JC; Timsit JF
    Crit Care; 2020 Jul; 24(1):458. PubMed ID: 32703235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
    Campbell D; Mudge DW; Craig JC; Johnson DW; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004679. PubMed ID: 28390069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exit-site care in Austrian peritoneal dialysis centers -- a nationwide survey.
    Kopriva-Altfahrt G; König P; Mündle M; Prischl F; Roob JM; Wiesholzer M; Vychytil A; ; Arneitz K; Karner A; Artes R; Wolf E; Auinger M; Pawlak A; Fraberger J; Hofbauer S; Galvan G; Salmhofer H; Pichler B; Wazel M; Gruber M; Thonhofer A; Hager A; Malajner S; Heiss S; Braunsteiner T; Zweiffler M; König P; Rudnicki M; Kogler R; Kohlhauser D; Wiesinger T; Kopriva-Altfahrt G; Moser E; Kotanko P; Loibner H; Nitz H; Miska HJ; Wenzel R; Wölfer M; Mündle M; Breuss H; Hölzl B; Prischi F; Schmekal B; Riener EM; Roob JM; Wonisch W; Vikydal R; Vychytil A; Frank B; Wieser C; Wiesholzer M; Pokorny K
    Perit Dial Int; 2009; 29(3):330-9. PubMed ID: 19458307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial.
    Timsit JF; Schwebel C; Bouadma L; Geffroy A; Garrouste-Orgeas M; Pease S; Herault MC; Haouache H; Calvino-Gunther S; Gestin B; Armand-Lefevre L; Leflon V; Chaplain C; Benali A; Francais A; Adrie C; Zahar JR; Thuong M; Arrault X; Croize J; Lucet JC;
    JAMA; 2009 Mar; 301(12):1231-41. PubMed ID: 19318651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
    Garland JS; Alex CP; Mueller CD; Otten D; Shivpuri C; Harris MC; Naples M; Pellegrini J; Buck RK; McAuliffe TL; Goldmann DA; Maki DG
    Pediatrics; 2001 Jun; 107(6):1431-6. PubMed ID: 11389271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorhexidine for routine PD catheter exit-site care.
    Olga B; Fotis Z; Margarita I; Sofia X; Konstantinos S
    Int Urol Nephrol; 2016 Sep; 48(9):1543-6. PubMed ID: 27432412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.